NCT01815541View on ClinicalTrials.gov

Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions
Osteoarticular Infection
Interventions
DRUG

teicoplanin

Trial Locations (1)

80054

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT01815541 - Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study | Biotech Hunter | Biotech Hunter